Mostrar el registro sencillo del ítem

dc.contributor.author
Sookoian, Silvia Cristina
dc.contributor.author
Pirola, Carlos José
dc.date.available
2018-03-14T20:16:35Z
dc.date.issued
2015-04
dc.identifier.citation
Sookoian, Silvia Cristina; Pirola, Carlos José; TM6SF2 as a genetic risk factor for fibrosis.; John Wiley & Sons Inc; Hepatology (baltimore, Md.); 62; 4; 4-2015; 1321-1322
dc.identifier.issn
0270-9139
dc.identifier.uri
http://hdl.handle.net/11336/38801
dc.description.abstract
We thank Daly et al. for their interest in our study on the role of TM6SF2 rs58542926 in NAFLD. In our study we confirmed and extended the original findings of Kozlitina et al. who reported a significant association of this variant with liver fat content. We further suggested that rs58542926 regulates liver transcript and protein expression in an allele-specific manner. As Daly et al. noticed, neither we nor others observed an association with liver fibrosis, however, the variant was significantly associated with the degree of histological steatosis and NASH. In fact, a large study from Italy showed that the association with fibrosis was completely abolished after adjusting for NASH (4). Daly et al. misunderstood the concept of ?population stratification? in the 1000 genomes; as shown in Figure 1 there is a clear stratification in the European Ancestry sample that Liu et al. used as control group (5). Population stratification and its effect in spurious allelic associations is largely known , it does affect the frequency of allele variants, but it is not dependent on it . Daly et al. also raised some concerns about the controls we used: subjects whose ultrasonography and laboratory data indicated absence of disease. Conversely, the 1000 genome project used by Liu et al. (5) contains no phenotypic data and the participants cannot be matched for sex or age. In addition, we disagree that we have limited power to detect association with fibrosis. In fact, assuming the additive model of inheritance for an OR of 2.9 (the one reported by Liu et at. and a realistic prevalence of advanced fibrosis of 20%, the power of our sample would be ~99% for a p-value=0.05. In this association sub-study we did not use healthy controls as Daly et al mistakenly stated but NAFLD patients proven by liver biopsy.Furthermore, we agree that rs58542926 is not a rare variant; however, it has been shown that homozygous TT subjects are in fact uncommon around the world.Finally, in our view, the association of the variant with fibrosis is still inconclusive. The assumption of Liu et al. attributing the variant a ?fibrogenic? effect per se (5) is difficult to reconcile with the knowledge gained on hepatic fibrogenesis as a wound-healing response to repeated injury. Further experimental work is required to prove that rs58542926 is involved in fibrosis. Specifically, it would be very interesting to understand how the variant could possibly induce liver fibrosis without affecting the main disease phenotype, NASH/NAFLD as Liu t al. postulated.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
John Wiley & Sons Inc
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
Tm6sf2
dc.subject
Variant
dc.subject
Gnetics
dc.subject
Nafld
dc.subject.classification
Inmunología
dc.subject.classification
Medicina Básica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
TM6SF2 as a genetic risk factor for fibrosis.
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2018-03-13T13:57:31Z
dc.journal.volume
62
dc.journal.number
4
dc.journal.pagination
1321-1322
dc.journal.pais
Estados Unidos
dc.journal.ciudad
New York
dc.description.fil
Fil: Sookoian, Silvia Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina
dc.description.fil
Fil: Pirola, Carlos José. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina
dc.journal.title
Hepatology (baltimore, Md.)
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://onlinelibrary.wiley.com/doi/10.1002/hep.27656/full
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1002/hep.27656